Press Releases April 27, 2026 06:30 AM

Parsons Marks Groundbreaking of SR 400 Express Lanes Project in Georgia

Parsons Leads Design on $4.6 Billion SR 400 Express Lanes Project in Georgia, the Largest Transportation P3 in the U.S.

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
PSN

Parsons Corporation, a leading national security and infrastructure technology company, has commenced work as lead designer on the State Route 400 Express Lanes Project in Georgia. This $4.6 billion initiative, the largest transportation public-private partnership in the U.S., aims to improve mobility, reduce congestion, and promote economic growth in a key Atlanta corridor by adding dynamically priced express lanes over 16 miles. Parsons' involvement reflects its extensive experience in delivering large-scale infrastructure projects that enhance transportation systems and regional connectivity.

Parsons Marks Groundbreaking of SR 400 Express Lanes Project in Georgia
PSN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Parsons serves as lead designer for the $4.6 billion SR 400 Express Lanes Project, adding express lanes along a 16-mile heavily traveled corridor in Georgia.
  • The project is the largest transportation public-private partnership in the U.S., aiming to improve mobility, travel reliability, and support future transit options.
  • Parsons leverages decades of experience in infrastructure design, contributing to modernization efforts in Georgia's transportation network.

CHANTILLY, Va., April 27, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) joined the Georgia Department of Transportation (GDOT), the State Road and Tollway Authority (SRTA), project partners, and community leaders to mark the groundbreaking of the State Route 400 (SR 400) Express Lanes Project on April 22. SR 400 is the largest transportation infrastructure project in Georgia’s history and the largest transportation public-private partnership (P3) project in the United States.

Parsons serves as the lead designer on the SR 400 Peach Partners team, supporting delivery of the approximately $4.6 billion project. The project will add new, dynamically priced express lanes along a 16-mile corridor from the North Springs MARTA station in Fulton County to McFarland Parkway in Forsyth County, improving mobility and the regional economy, enhancing travel reliability, and supporting future transit opportunities in one of the region’s most heavily traveled corridors.

“This project represents a significant investment in the future of transportation in Georgia,” said Mark Fialkowski, president of Infrastructure North America, Parsons Corporation. “Parsons brings deep experience delivering complex, large-scale infrastructure programs, and we are proud to support this transformative project that will improve mobility, strengthen regional connectivity, and support long-term economic growth.”

The SR 400 Express Lanes Project is a key component of Georgia’s Major Mobility Investment Program and is designed to address increasing congestion while providing reliable travel options for commuters and freight. The project will also enable future multimodal improvements, including transit enhancements along the corridor.

Parsons has supported critical infrastructure programs across Georgia for decades, providing engineering, design, and program management services that help modernize transportation systems and connect communities across the state. The company’s role on the SR 400 project reflects its continued commitment to delivering innovative, resilient infrastructure solutions that meet the evolving needs of its clients.

Parsons has more than half a century of experience designing, delivering, and protecting the infrastructure that connects our communities around the world, including roads and highways; bridges; passenger and freight rail; public transit; airports; and ports and waterways. Our experience includes more than 10,000 miles of roadways, 4,500 bridges, and more than 50 advanced traffic management system deployments that help cities and states improve safety and travel efficiency while also reducing emissions and energy costs to enhance the quality of life in the communities we serve.

To learn more about Parsons’ road and highway expertise, visit www.Parsons.com/road-highway/.

About Parsons
Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and global infrastructure markets, with capabilities across cyber and electronic warfare, space and missile defense, transportation, water and environment, urban development, and critical infrastructure protection. Please visit Parsons.com and follow us on LinkedIn to learn how we’re making an impact.

Media Contact:
Bernadette Miller
+1 980.253.9781
[email protected]

Investor Relations Contact:
Dave Spille
+ 1 703.775.6191
[email protected]


Risks

  • Execution risks inherent in large-scale infrastructure projects, including potential delays or cost overruns, could impact project timelines and profitability for Parsons.
  • Dependence on public-private partnership structures subjects project outcomes to governmental and regulatory approvals and changes, which could create uncertainties.
  • Traffic and revenue projections tied to dynamically priced express lanes could be affected by economic conditions and commuter behavior, impacting long-term project success.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026